January 21, 2021

The Niche

Trusted stem cell blog & resources


4 min read

ABC News just reported that the FDA is allgedly “cracking down” on the publicly traded company, MiMedx (MDXG), which sells a placental derivative touted for healing powers. The Wall Street Journal is also following the story. According to ABC News: MiMedx is a publically traded, for-profit company that takes donated human placentas — solicited via a website featuring babies and a cartoon butterfly — and turns them into health products. These can be used as skin grafts or injections, and they’re intended to treat inflammation and scar …Read More